Skip to content
brainology

Sleep Medicine and Sleep Testing

Your AHI Is Only Part of the Sleep Study: Understanding RDI, RERAs, and Sleep Fragmentation

The apnea-hypopnea index is important, but it is not a complete summary of breathing during sleep. RERAs, RDI, sleep fragmentation, oxygen burden, REM sleep, body position, and the difference between laboratory and home testing can all change how a sleep study should be interpreted.

Conceptual illustration for ahi, rdi and reras, with themes of Breathing events, Arousals and Sleep fragmentation.
Brainology editorial illustration. Conceptual, not a patient recording or diagnostic image.

A single sleep-study number can hide important details

Many patients leave a sleep study with one number: the apnea-hypopnea index, or AHI. An AHI below 5 is often described as normal. Values from 5 to under 15, 15 to under 30, and 30 or more events per hour are commonly labeled mild, moderate, and severe obstructive sleep apnea.

Those categories are useful, but the AHI is not a complete measure of sleep quality, oxygen stress, symptoms, or individual health risk. Two people with the same AHI can have very different nights. One may have brief events with minimal oxygen change. The other may have prolonged events, repeated arousals, or disease concentrated in REM sleep or while sleeping on the back.

A sleep study should therefore be interpreted as a physiologic record, not just a score.

What AHI, RDI, and REI actually count

The terms on a sleep report look similar, but they are not interchangeable.

Measure What it usually includes Denominator
AHI Apneas plus hypopneas Hours of measured sleep
RDI Apneas, hypopneas, and respiratory effort-related arousals, or RERAs Hours of measured sleep
REI Respiratory events detected by a home sleep apnea test Hours of monitoring or estimated sleep time, depending on the device

An apnea is a near-complete pause in airflow. A hypopnea is a partial reduction in airflow that meets defined duration and consequence criteria. A RERA is a sequence of increasingly effortful or flow-limited breaths that ends in an EEG arousal but does not qualify as an apnea or hypopnea.

Under the American Academy of Sleep Medicine definition, RDI is calculated by adding apneas, hypopneas, and RERAs and dividing by total sleep time. However, laboratories, device manufacturers, and payers have not always used “RDI” consistently. The report should define how its number was calculated.

Why RERAs matter even without a large oxygen drop

The brain can briefly shift toward wakefulness when airflow becomes limited and breathing effort rises. These arousals may be too short for the patient to remember, yet repeated interruptions can fragment sleep.

This is why someone may report unrefreshing sleep, fatigue, morning headaches, insomnia, or impaired concentration even when major oxygen drops are uncommon. These symptoms are not specific to sleep-disordered breathing, so RERAs should not be used to explain every case of fatigue. Insomnia, insufficient sleep, circadian disorders, medications, depression, pain, movement disorders, and medical illness may produce similar complaints.

The AASM has stated that attended polysomnography should include arousal-based scoring. Its recommended hypopnea rule recognizes a breathing reduction lasting at least 10 seconds when it is accompanied by either at least a 3% oxygen desaturation or an EEG arousal. The AASM also supports reporting an RDI that includes RERAs.

Patients whose abnormalities are mainly RERAs were historically described as having upper airway resistance syndrome. Current AASM diagnostic classification places this pattern within obstructive sleep apnea rather than treating it as a completely separate disorder.

Different hypopnea rules can produce different AHI values

Not every laboratory or payer uses the same hypopnea definition. A rule that requires a 4% oxygen desaturation will exclude events that cause an EEG arousal or a 3% desaturation without reaching 4%. As a result, the same raw sleep recording can produce different AHIs under different scoring rules.

This does not mean one result is fraudulent. It means the report must be read with its scoring method in mind. Research has demonstrated that changing the hypopnea definition can materially change the calculated AHI and, in some cases, whether a person crosses a diagnostic or treatment threshold.

When symptoms and the reported AHI do not fit, useful questions include:

  • Which hypopnea rule was used?
  • Were arousal-associated hypopneas counted?
  • Were RERAs scored and was an RDI reported?
  • Did the study record EEG and actual sleep time?

Home testing can underestimate event frequency

Most home sleep apnea tests do not record the EEG signals needed to determine exactly when a person is asleep. They often divide respiratory events by monitoring time rather than confirmed sleep time. If the device records for eight hours but the patient sleeps for only six, the resulting REI can be lower than an AHI calculated using six hours of actual sleep.

In a 2017 analysis that rescored laboratory studies as though sleep staging were unavailable, 26.4% of patients with obstructive sleep apnea moved at least one severity category lower. This was a modeling study from a sleep-center population, not a direct comparison of every modern home device, but it illustrates the denominator problem.

Home testing also usually cannot identify EEG arousals and may not capture RERAs reliably. It remains appropriate for selected uncomplicated adults with a high likelihood of moderate to severe obstructive sleep apnea. The AASM recommends laboratory polysomnography when a single home test is negative, inconclusive, or technically inadequate despite ongoing clinical concern. Laboratory testing is also preferred in several complex situations, including suspected hypoventilation, significant cardiorespiratory disease, neuromuscular weakness, chronic opioid use, prior stroke, or severe insomnia.

AHI does not measure the depth or duration of oxygen stress

AHI counts how often events occur, but it does not directly describe how long they last or how deeply oxygen falls. AHI also averages the entire night, which can obscure severe breathing abnormalities limited to REM sleep or the supine position.

Other report elements may add context:

  • oxygen nadir and time spent below 90% saturation
  • oxygen desaturation index
  • REM and non-REM AHI
  • supine and nonsupine AHI
  • event duration
  • arousal index and sleep efficiency
  • central apnea index

Research metrics such as “hypoxic burden” estimate the depth and duration of event-related oxygen changes. In observational cohorts, hypoxic burden predicted cardiovascular mortality more consistently than AHI. Separate cohort research linked greater overall arousal burden with mortality, particularly in women. These studies show that physiologic detail may carry information beyond event frequency, but they do not prove that a particular RERA or arousal causes cardiovascular disease. Many newer metrics are also not yet routine treatment thresholds.

Symptoms and medical context still matter

A higher AHI generally indicates more frequent breathing events, but symptoms do not rise in a perfectly linear way. Some people with severe OSA report little sleepiness. Others with a lower event index have prominent fatigue, insomnia, mood changes, or cognitive complaints.

Treatment decisions should integrate the full study, symptoms, oxygenation, sleep stage and position, cardiovascular and neurologic conditions, occupation, driving risk, and patient preferences. A low AHI should not automatically end the evaluation when clinical concern remains. It also should not prompt treatment solely because one additional metric is slightly elevated. The interpretation must be individualized.

Questions to ask about your sleep-study report

Consider asking your sleep clinician:

  1. Is this number an AHI, RDI, or REI?
  2. Was it calculated from confirmed sleep time or monitoring time?
  3. Were arousal-based hypopneas and RERAs scored?
  4. Was disease worse during REM sleep or while I was on my back?
  5. What were my oxygen nadir, oxygen burden, and arousal index?
  6. If my home test was negative, do my symptoms justify polysomnography?

Brainology can review the raw data and full context of a sleep study when the summary number does not match the patient’s symptoms or clinical risk. The goal is not to find a diagnosis in every tired patient. It is to avoid losing meaningful physiology inside a single average.

[!CALLOUT] ⚕️

Medical disclaimer: This draft is for education and does not replace an individualized sleep evaluation. Do not start or stop PAP therapy, oxygen, medication, or another treatment based only on a single sleep-study value.

References

  1. Malhotra RK, et al. Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement. Journal of Clinical Sleep Medicine. 2018;14(7):1245-1247. PubMed | PMC | DOI
  2. Kapur VK, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine. 2017;13(3):479-504. PubMed | PMC | DOI
  3. Rosen IM, et al. Clinical Use of a Home Sleep Apnea Test: An Updated American Academy of Sleep Medicine Position Statement. Journal of Clinical Sleep Medicine. 2018;14(12):2075-2077. PubMed | DOI
  4. Bianchi MT, Goparaju B. Potential Underestimation of Sleep Apnea Severity by At-Home Kits: Rescoring In-Laboratory Polysomnography Without Sleep Staging. Journal of Clinical Sleep Medicine. 2017;13(4):551-555. PubMed | PMC | DOI
  5. Ruehland WR, et al. The New AASM Criteria for Scoring Hypopneas: Impact on the Apnea Hypopnea Index. Sleep. 2009;32(2):150-157. PubMed | PMC
  6. Azarbarzin A, et al. The Hypoxic Burden of Sleep Apnoea Predicts Cardiovascular Disease-Related Mortality. European Heart Journal. 2019;40(14):1149-1157. PubMed | PMC | DOI
  7. Shahrbabaki SS, et al. Sleep Arousal Burden Is Associated With Long-Term All-Cause and Cardiovascular Mortality in 8,001 Community-Dwelling Older Men and Women. European Heart Journal. 2021;42(21):2088-2099. PubMed | PMC | DOI